Baveno VII Endoscopy-Sparing Criteria in MASLD- Predominant Compensated Cirrhosis: A Prospective Validation from a Gulf Arab Population (Kuwait)

Inside the human body, the liver acts as a massive chemical processing plant, filtering blood and removing toxins. Over time, if this organ is damaged by viruses, alcohol, or metabolic issues, it can become scarred and stiff, a condition known as cirrhosis. As the liver hardens, the pressure inside its blood vessels rises, much like a clogged pipe building up water pressure. This high pressure can cause weak, swollen veins to form in the esophagus, similar to varicose veins in the legs. If these veins burst, they can cause life-threatening bleeding. For decades, the standard way to check for these dangerous veins has been to slide a camera down a patient's throat, a procedure that is invasive, requires sedation, and can be uncomfortable. However, not every patient with a scarred liver has these dangerous veins. Doctors have long sought a way to identify the low-risk patients who could safely skip the camera test, saving them from unnecessary procedures and the healthcare system from extra costs.

In recent years, a method called transient elastography has emerged as a promising alternative. This technique uses a specialized device that gently taps the skin over the liver to measure its stiffness. A stiffer liver usually indicates more scarring and higher pressure. By combining this stiffness measurement with a simple blood test for platelets, which tend to drop as liver pressure rises, doctors can create a safety profile for a patient. International guidelines, known as the Baveno criteria, have established specific thresholds for these measurements. If a patient's liver is soft enough and their platelet count is high enough, the guidelines suggest they are unlikely to have dangerous veins and can avoid the camera test. But these rules were largely developed in populations where liver disease was caused by viruses or alcohol. It remained unclear if these same rules would work safely in regions where liver disease is driven primarily by metabolic factors, such as obesity and diabetes, which are increasingly common in the Gulf Arab world.

A team of researchers at Al Adan Hospital in Kuwait set out to test these rules in their local population. They studied 380 consecutive adults who had been diagnosed with compensated cirrhosis, meaning their liver was scarred but still functioning well enough to keep them out of immediate danger. The researchers wanted to see if the current safety rules could accurately predict who did not need the camera test, and if they needed to adjust the rules for patients with metabolic liver disease, particularly those who were obese. To do this, every single patient in the study underwent the standard camera test to check for dangerous veins, providing a perfect reference point to see if the non-invasive measurements were correct.

The study focused heavily on the Baveno VII criteria, the most recent set of international guidelines. The researchers found that when they applied the rule stating that a patient could skip the camera test if their liver stiffness was below a certain level and their platelet count was above a specific number, the approach was remarkably safe. Out of the 380 patients, about 38 percent met these criteria and were deemed low-risk. Among this group, only two patients actually had dangerous veins that the test had missed. This resulted in a miss rate of just 1.4 percent, which is well below the safety limit of 5 percent that doctors require to feel confident skipping the invasive procedure. This finding confirmed that the current rules work well even in a population where nearly two-thirds of the patients had liver disease linked to metabolic issues and where the average body mass index was quite high.

However, the study also investigated a more relaxed version of the rules, known as the Expanded Baveno VI criteria, which allows for a higher liver stiffness measurement before triggering a camera test. The researchers discovered that this relaxed rule was dangerous for a specific group: patients with metabolic liver disease who were also obese. When applied to this group, the relaxed rule missed dangerous veins in 7.1 percent of cases, a number that far exceeded the safe limit. The data showed that in obese patients, the fatty tissue in the liver can make the organ appear stiffer than it truly is, leading the relaxed rule to incorrectly assume that a patient is safe when they are not. Consequently, the researchers concluded that this more lenient rule should not be used for obese patients with metabolic liver disease, as it would expose them to unnecessary risk.

The team also explored a more complex calculation called the ANTICIPATE-NASH model, which takes body weight into account to refine the risk prediction. They found that using this model improved the ability to correctly identify patients who definitely needed the camera test. In the group of obese patients with metabolic liver disease, this model was significantly better at spotting those with dangerous veins compared to using liver stiffness measurements alone. This suggests that by adjusting for body weight, doctors can be more precise about who needs treatment, avoiding unnecessary procedures for those who are safe while ensuring those at risk receive the care they need.

Ultimately, this study provides a clear, evidence-based roadmap for doctors in Kuwait and similar regions. It confirms that the standard safety rules for skipping the camera test are reliable for almost all patients, but it draws a firm line against using the more lenient rules for obese patients with metabolic liver disease. By following these refined guidelines, healthcare providers can safely reduce the number of invasive camera tests performed, focusing their resources on the patients who truly need them. The research highlights that while the underlying biology of liver disease may vary across different populations, the tools to manage it can be adapted with careful, data-driven adjustments to ensure patient safety remains the top priority.